Physician profile
David Scott Estes
NPI 1013958008
$11,168.76
in general payments reported to CMS, 2019-2025
45 companies · $1,397 in 2025
The $1,397 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,829 · 2020: $1,506 · 2021: $1,676 · 2022: $1,653 · 2023: $1,552 · 2024: $1,555 · 2025: $1,397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,503.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,191.45 | 2019-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $1,152.97 | 2019-2025 | Evenity, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $1,094.03 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $771.56 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $763.62 | 2019-2025 | Jardiance |
| Pfizer INC. | $709.12 | 2019-2025 | |
| Novo Nordisk INC | $554.88 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $520.56 | 2021-2024 | Freestyle Libre |
| Astellas Pharma US INC | $497.09 | 2019-2025 | Veozah, Myrbetriq |
| Lilly USA, LLC | $417.13 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Allergan, INC. | $389.04 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $363.35 | 2020-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $273.79 | 2021-2025 | |
| Amarin Pharma, INC. | $232.54 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $221.78 | 2019-2025 | Xifaxan, Trulance |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Estes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.